生物活性 | |||
---|---|---|---|
描述 | NFATc1-IN-1 is a potent inhibitor of RANKL-induced osteoclast formation, demonstrating an IC50 of 1.57 μM. It exhibits anti-osteoclastogenic effects by reducing RANKL-induced NFATc1 nuclear translocation and is suitable for research into osteoclastic diseases[1]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.67mL 0.53mL 0.27mL |
13.33mL 2.67mL 1.33mL |
26.66mL 5.33mL 2.67mL |
参考文献 |
---|